» Articles » PMID: 32783070

Postoperative Renal Morbidity and Mortality After Volume Replacement with Hydroxyethyl Starch 130/0.4 or Albumin During Surgery: a Propensity Score-matched Study

Overview
Journal J Anesth
Specialty Anesthesiology
Date 2020 Aug 13
PMID 32783070
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We aimed to compare retrospectively the rates of renal morbidity and mortality in surgical patients receiving 6% HES 130/0.4 to those receiving albumin.

Methods: From a Japanese nationwide medical database between 2014 and 2016, we identified adults who received HES 130/0.4 (HES group) or albumin (albumin group) as a single colloid solution on the day of surgery. After propensity score matching, the two groups were analyzed with χ or Mann Whitney U test. The primary outcome was the incidence of acute kidney injury (AKI). Secondary outcomes included the incidence of renal-replacement therapy, hospital length of stay, in-hospital 30-day mortality, the use of vasoactive agents, and the fluid requirement on the day of surgery.

Results: Of 76,048 patients in the database, propensity score matching identified 289 matched pairs. There was no statistically significant difference in the incidence of AKI between the HES and the albumin group (15.2% vs. 20.8%, respectively: P = 0.08). The secondary outcomes did not differ between groups except the following. Median hospital stay was 5 days shorter in the HES group (18 vs. 23 days; P < 0.001), and the median net fluid requirement on the day of surgery was 15 mL/kg lower in the HES group (140 vs. 155 mL/kg, respectively; P = 0.01).

Conclusions: Postoperative renal morbidity and mortality did not differ between patients receiving HES 130/0.4 and those receiving albumin. HES 130/0.4 was associated with shorter hospital stay and less fluid requirement compared to albumin. These findings support the use of 6% HES 130/0.4 for perioperative volume replacement as an alternative to albumin.

Trial Registration: UMIN000027896 and the date of registration was June 30, 2017 at https://www.umin.ac.jp/ctr/index-j.html .

References
1.
Frenette A, Bouchard J, Bernier P, Charbonneau A, Nguyen L, Rioux J . Albumin administration is associated with acute kidney injury in cardiac surgery: a propensity score analysis. Crit Care. 2014; 18(6):602. PMC: 4256900. DOI: 10.1186/s13054-014-0602-1. View

2.
Rabin J, Meyenburg T, Lowery A, Rouse M, Gammie J, Herr D . Restricted Albumin Utilization Is Safe and Cost Effective in a Cardiac Surgery Intensive Care Unit. Ann Thorac Surg. 2016; 104(1):42-48. DOI: 10.1016/j.athoracsur.2016.10.018. View

3.
Trof R, Sukul S, Twisk J, Girbes A, Groeneveld A . Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia. Intensive Care Med. 2010; 36(4):697-701. PMC: 2837190. DOI: 10.1007/s00134-010-1776-x. View

4.
Gao T, Li N, Zhang J, Xi F, Chen Q, Zhu W . Restricted intravenous fluid regimen reduces the rate of postoperative complications and alters immunological activity of elderly patients operated for abdominal cancer: a randomized prospective clinical trail. World J Surg. 2012; 36(5):993-1002. DOI: 10.1007/s00268-012-1516-1. View

5.
Brandstrup B, Svensen C, Engquist A . Hemorrhage and operation cause a contraction of the extracellular space needing replacement--evidence and implications? A systematic review. Surgery. 2006; 139(3):419-32. DOI: 10.1016/j.surg.2005.07.035. View